You have 9 free searches left this month | to do more

lenalidomide

Lenalidomide is a drug used to treat Multiple Myeloma, Chronic Lymphocytic Leukemia, Lymphoma, and other conditions. Lenalidomide is being actively studied in 273 studies and prior, has been studied in 248.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterMayo ClinicIrene Ghobrial, MD
National Cancer Institute (NCI)Washington University School of MedicineJacob Laubach
CelgeneM D Anderson Cancer CenterZhao Weili
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Active, not recruiting
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-06-11
Jun 11, 2021
A
Active, not recruiting
  • Lymphoma
  • Lenalidomide
  • Philadelphia, Pennsylvania
    Jakub Svoboda
2021-10-04
Oct 4, 2021
S
Recruiting
  • Smouldering Myeloma
  • Brno, Czechia
  • +15 more
2021-08-20
Aug 20, 2021
U
Active, not recruiting
  • Multiple Myeloma
  • Lenalidomide
  • +3 more
  • Chicago, Illinois
  • +2 more
2021-06-29
Jun 29, 2021
W
Active, not recruiting
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
2021-05-13
May 13, 2021
H
Recruiting
  • Central Nervous System Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib
  • +2 more
  • Zhengzhou, Henan, China
    Henan cancer hospital
2021-06-16
Jun 16, 2021
M
Active, not recruiting
  • Mantle Cell Lymphoma
  • Untreated
  • Lenalidomide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
2021-07-13
Jul 13, 2021
U
Active, not recruiting
  • Lymphoma
  • Rituximab
  • Lenalidomide
  • Sacramento, California
    University of California Davis Cancer Center
2021-02-04
Feb 4, 2021
H
Completed
  • Multiple Myeloma
  • Lenalidomide
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-10-08
Oct 8, 2021
N
Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Lenalidomide
  • XRT, 54-59.4 Gy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-10-13
Oct 13, 2021
M
Not yet recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
    University of Miami
2021-09-09
Sep 9, 2021
U
Active, not recruiting
  • Richter's Syndrome
  • CLL
  • La Jolla, California
    University of California, San Diego
2021-04-08
Apr 8, 2021
B
Recruiting
  • EBV Infection
  • PD1 antibody
  • lenalidomide
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
2021-06-27
Jun 27, 2021
T
Completed
  • Relapsed and/or Refractory Multiple Myeloma
  • Tokyo, Japan
    Takeda Selected Site
2021-06-03
Jun 3, 2021
H
Recruiting
  • Primary Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-01-30
Jan 30, 2021
W
Active, not recruiting
  • Multiple Myeloma
  • Aurora, Colorado
  • +1 more
2021-09-02
Sep 2, 2021
S
Recruiting
  • Primary Central Nervous System Lymphoma
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
2021-06-20
Jun 20, 2021
H
Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
2021-08-15
Aug 15, 2021
M
Recruiting
  • Alkylating Agent-Related Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Laboratory Biomarker Analysis
  • Lenalidomide
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-16
Jun 16, 2021
W
Completed
  • Chronic Lymphocytic Leukemia
  • New York, New York
    Weill Cornell Medical College
2021-03-23
Mar 23, 2021
B
Recruiting
  • Follicular Lymphoma and Marginal Zone Lymphoma
  • Recombinant Humanized Monoclonal Antibody MIL62 Injection
  • Lenalidomide
  • Beijing, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
2021-06-15
Jun 15, 2021
F
Active, not recruiting
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
2021-04-13
Apr 13, 2021
D
Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Lenalidomide
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2020-11-23
Nov 23, 2020